ERBB2 and breast carcinoma: To assess whether there was any correlation between ER/PR/HER2 presence, or histologic subtype of breast cancer, and HPA labeling, we collated the HPA labelling patterns across a number of breast cancer cell lines reported in the literature and did not find any correlation between HPA labeling and receptor status or histologic subtype (Supplementary Table 5).